Cenova Capital — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Vivace Therapeuticsvivacetherapeutics.comJul 2026
Vivace Therapeutics is an oncology-focused drug discovery and development company creating small-molecule inhibitors targeting the Hippo-YAP pathway to treat cancers including mesothelioma, meningioma, and various other tumor types.
BiotechHealthtechMedical DevicesSan Mateo, US
Shuang Qiao(Executive Officer, Director)Sheng Ding(Executive Officer)
BoardEdward Hu(Director)Jun Wu(Director)Jake Simson(Director)inTim Shannon(Director)in
Co-investorsCanaan PartnersRA CapitalMission Biocapital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.